Angelica Ferguson

I received my PhD in Chemical Biology from Cornell University, Weill Cornell Medicine via the Tri-Institutional PhD Program in Chemical Biology (Rockefeller University, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center). My graduate studies focused on elucidating the mechanism of protein synthesis in human cells by performing biochemical, biophysical and structural studies of the human ribosome and translation machinery. I joined the LaCava group in 2019 as a post-doctoral researcher where I applied my biochemistry and structural biology background to probing the LINE-1 RNP with the goal of obtaining mechanistic insights into the retrotransposition life cycle and gaining a deeper understanding of retrotransposon-mediated drivers of disease.